{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:20:02Z","timestamp":1792894802834,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["270650915"],"award-info":[{"award-number":["270650915"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["417677437"],"award-info":[{"award-number":["417677437"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["267192581"],"award-info":[{"award-number":["267192581"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["542770124"],"award-info":[{"award-number":["542770124"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["417919780"],"award-info":[{"award-number":["417919780"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 208\/761-1 FUGG"],"award-info":[{"award-number":["INST 208\/761-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["267192581"],"award-info":[{"award-number":["267192581"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["270650915"],"award-info":[{"award-number":["270650915"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["270650915"],"award-info":[{"award-number":["270650915"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Katharina-Hardt Foundation, Christiane und Claudia Hempel foundation and L\u00f6wenstern e.V."},{"name":"Elterninitiative Kinderkrebsklinik e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A major obstacle for the successful treatment of cancer is the presence or development of resistance mechanisms toward therapeutic intervention. In urothelial cancer, cisplatin-based regimens are still routinely employed, and multiple pathways contribute to chemoresistance. Since the identification of heat shock protein 90 (HSP90) as potential cancer target, various HSP90 inhibitors have been developed and evaluated in clinical trials. However, limited efficacy has been observed, mainly caused by dose-limiting toxicity and the concomitant induction of a cytoprotective heat shock response (HSR). To avoid this effect, inhibitors targeting the C-terminal domain (CTD) of HSP90 that do not elicit an HSR have been put forward. Additionally, the crosstalk between autophagy and HSP90 is currently being explored, since both processes work together in proteostasis, and the modulation of autophagy might be helpful in order to improve the efficacy of HSP90 inhibitors. We demonstrate that the second-generation small-molecule inhibitor VWK147 targeting HSP90 CTD dimerization induces cell death in both cisplatin-sensitive and cisplatin-resistant urothelial carcinoma cells. The treatment with VWK147 in these cells led to the destabilization of classical HSP90 client proteins without triggering an HSR. Additionally, we observe that VWK147 re-sensitizes resistant urothelial carcinoma cells to cisplatin and\u2014in combination with mTOR inhibition\u2014synergistically kills cisplatin-sensitive and -resistant cells, in contrast to what is observed upon treatment with the N-terminal domain-targeting HSP90 inhibitor 17-AAG. This synergy may be explained by VWK147-mediated inhibition of late autophagy events, and thus a blockade of autophagic flux. Finally, we also observed that VWK147 induces non-canonical LC3 lipidation, indicating that this compound exerts a broader effect on ion balance or pH of the endolysosomal system. VWK147 is a promising inhibitor that targets the C-terminal dimerization of HSP90 and simultaneously exhibits autophagy-modulating effects. This compound could potentially be an effective option for improving anti-cancer therapies and\/or overcoming treatment resistance.<\/jats:p>","DOI":"10.1038\/s41419-025-08330-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:54:47Z","timestamp":1766501687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Small-molecule inhibitor of C\u2011terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells"],"prefix":"10.1038","volume":"17","author":[{"given":"C\u00e9line","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-4121","authenticated-orcid":false,"given":"Yadong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitalij","family":"Woloschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0871-9165","authenticated-orcid":false,"given":"Niklas","family":"Dienstbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-1395","authenticated-orcid":false,"given":"Karina S.","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schl\u00fctermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Berning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Lungerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Mendiburo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-7708","authenticated-orcid":false,"given":"Christoph G. W.","family":"Gertzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-4737","authenticated-orcid":false,"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5236-942X","authenticated-orcid":false,"given":"Sebastian","family":"Wesselborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-1447","authenticated-orcid":false,"given":"Holger","family":"Gohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-7744","authenticated-orcid":false,"given":"Sanil","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4167-7806","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"8330_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14:105\u201311.","journal-title":"Cell Stress Chaperones"},{"key":"8330_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","volume":"38","author":"J Wu","year":"2017","unstructured":"Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. Heat shock proteins and cancer. Trends Pharm Sci. 2017;38:226\u201356.","journal-title":"Trends Pharm Sci"},{"key":"8330_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"8330_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1568009619666191202101330","volume":"20","author":"J Sanchez","year":"2020","unstructured":"Sanchez J, Carter TR, Cohen MS, Blagg BSJ. Old and new approaches to target the Hsp90 chaperone. Curr Cancer Drug Targets. 2020;20:253\u201370.","journal-title":"Curr Cancer Drug Targets"},{"key":"8330_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s40265-022-01764-6","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy SM. Pimitespib: first approval. Drugs. 2022;82:1413\u20138.","journal-title":"Drugs"},{"key":"8330_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4155\/fmc.14.154","volume":"7","author":"Y Wang","year":"2015","unstructured":"Wang Y, McAlpine SR. Heat-shock protein 90 inhibitors: will they ever succeed as chemotherapeutics?. Future Med Chem. 2015;7:87\u201390.","journal-title":"Future Med Chem"},{"key":"8330_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood-2017-10-810986","volume":"132","author":"S Bhatia","year":"2018","unstructured":"Bhatia S, Diedrich D, Frieg B, Ahlert H, Stein S, Bopp B, et al. Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response. Blood. 2018;132:307\u201320.","journal-title":"Blood"},{"key":"8330_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1021\/acscentsci.2c00013","volume":"8","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Spanier L, Bickel D, Dienstbier N, Woloschin V, Vogt M, et al. Development of a first-in-class small-molecule inhibitor of the C-terminal Hsp90 dimerization. ACS Cent Sci. 2022;8:636\u201355.","journal-title":"ACS Cent Sci"},{"key":"8330_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bbagen.2016.01.005","volume":"1860","author":"B Bopp","year":"2016","unstructured":"Bopp B, Ciglia E, Ouald-Chaib A, Groth G, Gohlke H, Jose J. Design and biological testing of peptidic dimerization inhibitors of human Hsp90 that target the C-terminal domain. Biochim Biophys Acta. 2016;1860:1043\u201355.","journal-title":"Biochim Biophys Acta"},{"key":"8330_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05373-9","volume":"13","author":"C Peng","year":"2022","unstructured":"Peng C, Zhao F, Li H, Li L, Yang Y, Liu F. HSP90 mediates the connection of multiple programmed cell death in diseases. Cell Death Dis. 2022;13:929.","journal-title":"Cell Death Dis"},{"key":"8330_CR11","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1042\/BCJ20160005","volume":"473","author":"C Prodromou","year":"2016","unstructured":"Prodromou C. Mechanisms of Hsp90 regulation. Biochem J. 2016;473:2439\u201352.","journal-title":"Biochem J"},{"key":"8330_CR12","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.apsb.2022.06.004","volume":"12","author":"L Zou","year":"2022","unstructured":"Zou L, Liao M, Zhen Y, Zhu S, Chen X, Zhang J, et al. Autophagy and beyond: unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications. Acta Pharm Sin B. 2022;12:3743\u201382.","journal-title":"Acta Pharm Sin B"},{"key":"8330_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"8330_CR14","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1073\/pnas.1100844108","volume":"108","author":"L Shang","year":"2011","unstructured":"Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci USA. 2011;108:4788\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8330_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-biochem-061516-044820","volume":"86","author":"JH Hurley","year":"2017","unstructured":"Hurley JH, Young LN. Mechanisms of autophagy initiation. Annu Rev Biochem. 2017;86:225\u201344.","journal-title":"Annu Rev Biochem"},{"key":"8330_CR16","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Zhang S, Mizushima N. Autophagy genes in biology and disease. Nat Rev Genet. 2023;24:382\u2013400.","DOI":"10.1038\/s41576-022-00562-w"},{"key":"8330_CR17","doi-asserted-by":"crossref","unstructured":"Johansen T, Lamark T. Selective autophagy: ATG8 family proteins, LIR motifs and cargo receptors. J Mol Biol. 2020;432:80\u2013103.","DOI":"10.1016\/j.jmb.2019.07.016"},{"key":"8330_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo1274","volume":"8","author":"J Durgan","year":"2022","unstructured":"Durgan J, Florey O. Many roads lead to CASM: diverse stimuli of noncanonical autophagy share a unifying molecular mechanism. Sci Adv. 2022;8:eabo1274.","journal-title":"Sci Adv"},{"key":"8330_CR19","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.molcel.2021.03.020","volume":"81","author":"J Durgan","year":"2021","unstructured":"Durgan J, Lystad AH, Sloan K, Carlsson SR, Wilson MI, Marcassa E, et al. Non-canonical autophagy drives alternative ATG8 conjugation to phosphatidylserine. Mol Cell. 2021;81:2031\u201340 e8.","journal-title":"Mol Cell"},{"key":"8330_CR20","doi-asserted-by":"crossref","unstructured":"Hooper KM, Jacquin E, Li T, Goodwin JM, Brumell JH, Durgan J, et al. V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy. J Cell Biol. 2022;221:e202105112.","DOI":"10.1083\/jcb.202105112"},{"key":"8330_CR21","doi-asserted-by":"crossref","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","DOI":"10.1038\/s41580-023-00585-z"},{"key":"8330_CR22","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8330_CR23","unstructured":"Kaseb H, Aeddula NR. Bladder cancer. Treasure Island (FL): StatPearls; 2023."},{"key":"8330_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"key":"8330_CR25","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.clgc.2017.10.011","volume":"16","author":"ST Liu","year":"2018","unstructured":"Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A. The current status and future role of the phosphoinositide 3 kinase\/AKT signaling pathway in urothelial cancer: an old pathway in the new immunotherapy era. Clin Genitourin Cancer. 2018;16:e269\u2013e76.","journal-title":"Clin Genitourin Cancer"},{"key":"8330_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114674","volume":"242","author":"Z Pan","year":"2022","unstructured":"Pan Z, Chen Y, Pang H, Wang X, Zhang Y, Xie X, et al. Design, synthesis, and biological evaluation of novel dual inhibitors of heat shock protein 90\/mammalian target of rapamycin (Hsp90\/mTOR) against bladder cancer cells. Eur J Med Chem. 2022;242:114674.","journal-title":"Eur J Med Chem"},{"key":"8330_CR27","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/jo402353z","volume":"79","author":"L Spanier","year":"2014","unstructured":"Spanier L, Ciglia E, Hansen FK, Kuna K, Frank W, Gohlke H, et al. Design, synthesis, and conformational analysis of trispyrimidonamides as alpha-helix mimetics. J Org Chem. 2014;79:1582\u201393.","journal-title":"J Org Chem"},{"key":"8330_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.molcel.2011.06.018","volume":"43","author":"JH Joo","year":"2011","unstructured":"Joo JH, Dorsey FC, Joshi A, Hennessy-Walters KM, Rose KL, McCastlain K, et al. Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell. 2011;43:572\u201385.","journal-title":"Mol Cell"},{"key":"8330_CR29","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1074\/jbc.275.14.10519","volume":"275","author":"J Lewis","year":"2000","unstructured":"Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L, et al. Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem. 2000;275:10519\u201326.","journal-title":"J Biol Chem"},{"key":"8330_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1101\/gad.10.12.1491","volume":"10","author":"L Stepanova","year":"1996","unstructured":"Stepanova L, Leng X, Parker SB, Harper JW. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 1996;10:1491\u2013502.","journal-title":"Genes Dev"},{"key":"8330_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02706-8","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, et al. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int. 2022;22:284.","journal-title":"Cancer Cell Int"},{"key":"8330_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1158\/1541-7786.MCR-13-0605","volume":"12","author":"J Acquaviva","year":"2014","unstructured":"Acquaviva J, He S, Sang J, Smith DL, Sequeira M, Zhang C, et al. mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesis. Mol Cancer Res. 2014;12:703\u201313.","journal-title":"Mol Cancer Res"},{"key":"8330_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"8330_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112820","volume":"208","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhou X. Research progress of mTOR inhibitors. Eur J Med Chem. 2020;208:112820.","journal-title":"Eur J Med Chem"},{"key":"8330_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/BLC-160065","volume":"2","author":"MJ Hoffmann","year":"2016","unstructured":"Hoffmann MJ, Koutsogiannouli E, Skowron MA, Pinkerneil M, Niegisch G, Brandt A, et al. The new immortalized uroepithelial cell line HBLAK contains defined genetic aberrations typical of early stage urothelial tumors. Bladder Cancer. 2016;2:449\u201363.","journal-title":"Bladder Cancer"},{"key":"8330_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3:452\u201360.","journal-title":"Autophagy"},{"key":"8330_CR37","doi-asserted-by":"publisher","first-page":"160 e1","DOI":"10.1016\/j.urolonc.2017.11.021","volume":"36","author":"D Schl\u00fctermann","year":"2018","unstructured":"Schl\u00fctermann D, Skowron MA, Berleth N, B\u00f6hler P, Deitersen J, Stuhldreier F, et al. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. Urol Oncol. 2018;36:160 e1\u2013e13.","journal-title":"Urol Oncol"},{"key":"8330_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nchembio.1681","volume":"10","author":"B Ronan","year":"2014","unstructured":"Ronan B, Flamand O, Vescovi L, Dureuil C, Durand L, Fassy F, et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol. 2014;10:1013\u20139.","journal-title":"Nat Chem Biol"},{"key":"8330_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molcel.2014.05.021","volume":"55","author":"HC Dooley","year":"2014","unstructured":"Dooley HC, Razi M, Polson HE, Girardin SE, Wilson MI, Tooze SA. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol Cell. 2014;55:238\u201352.","journal-title":"Mol Cell"},{"key":"8330_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jnci\/92.3.242","volume":"92","author":"MG Marcu","year":"2000","unstructured":"Marcu MG, Schulte TW, Neckers L. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. J Natl Cancer Inst. 2000;92:242\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"8330_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13277-015-4142-3","volume":"37","author":"B Wang","year":"2016","unstructured":"Wang B, Chen Z, Yu F, Chen Q, Tian Y, Ma S, et al. Hsp90 regulates autophagy and plays a role in cancer therapy. Tumour Biol. 2016;37:1\u20136.","journal-title":"Tumour Biol"},{"key":"8330_CR42","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1096\/fj.10-167676","volume":"25","author":"C Xu","year":"2011","unstructured":"Xu C, Liu J, Hsu LC, Luo Y, Xiang R, Chuang TH. Functional interaction of heat shock protein 90 and Beclin 1 modulates Toll-like receptor-mediated autophagy. FASEB J. 2011;25:2700\u201310.","journal-title":"FASEB J"},{"key":"8330_CR43","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1128\/MCB.02070-07","volume":"28","author":"U Bandyopadhyay","year":"2008","unstructured":"Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol. 2008;28:5747\u201363.","journal-title":"Mol Cell Biol"},{"key":"8330_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ejmech.2018.01.024","volume":"145","author":"Q Wei","year":"2018","unstructured":"Wei Q, Ning JY, Dai X, Gao YD, Su L, Zhao BX, et al. Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells. Eur J Med Chem. 2018;145:551\u20138.","journal-title":"Eur J Med Chem"},{"key":"8330_CR45","first-page":"958","volume":"14","author":"J Han","year":"2018","unstructured":"Han J, Goldstein LA, Hou W, Chatterjee S, Burns TF, Rabinowich H. HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC. Autophagy. 2018;14:958\u201371.","journal-title":"Autophagy"},{"key":"8330_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/ijo.2014.2727","volume":"46","author":"M Mori","year":"2015","unstructured":"Mori M, Hitora T, Nakamura O, Yamagami Y, Horie R, Nishimura H, et al. Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells. Int J Oncol. 2015;46:47\u201354.","journal-title":"Int J Oncol"},{"key":"8330_CR47","doi-asserted-by":"publisher","first-page":"e0177706","DOI":"10.1371\/journal.pone.0177706","volume":"12","author":"S Schaefer","year":"2017","unstructured":"Schaefer S, Svenstrup TH, Guerra B. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells. PLoS One. 2017;12:e0177706.","journal-title":"PLoS One"},{"key":"8330_CR48","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.7150\/thno.23304","volume":"8","author":"Y Sun","year":"2018","unstructured":"Sun Y, Huang YH, Huang FY, Mei WL, Liu Q, Wang CC, et al. 3\u2019-epi-12beta-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90\/Akt\/mTOR axis in lung cancer cells. Theranostics. 2018;8:2044\u201360.","journal-title":"Theranostics"},{"key":"8330_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"X Xiao","year":"2018","unstructured":"Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 2018;37:201.","journal-title":"J Exp Clin Cancer Res"},{"key":"8330_CR50","doi-asserted-by":"crossref","unstructured":"Polson HE, de Lartigue J, Rigden DJ, Reedijk M, Urbe S, Clague MJ, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy. 2010;6:506\u201322.","DOI":"10.4161\/auto.6.4.11863"},{"key":"8330_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ijc.20611","volume":"113","author":"R Bagatell","year":"2005","unstructured":"Bagatell R, Beliakoff J, David CL, Marron MT, Whitesell L. Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin. Int J Cancer. 2005;113:179\u201388.","journal-title":"Int J Cancer"},{"key":"8330_CR52","doi-asserted-by":"crossref","unstructured":"Ewers KM, Patil S, Kopp W, Thomale J, Quilitz T, Magerhans A, et al. HSP90 inhibition synergizes with cisplatin to eliminate basal-like pancreatic ductal adenocarcinoma cells. Cancers. 2021;13:6163.","DOI":"10.3390\/cancers13246163"},{"key":"8330_CR53","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1172\/JCI125963","volume":"129","author":"C Pan","year":"2019","unstructured":"Pan C, Chun J, Li D, Boese AC, Li J, Kang J, et al. Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation. J Clin Investig. 2019;129:4110\u201323.","journal-title":"J Clin Investig"},{"key":"8330_CR54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00280-022-04407-5","volume":"89","author":"L Schmidt","year":"2022","unstructured":"Schmidt L, Issa II, Haraldsdottir H, Hald JL, Schmitz A, Due H, et al. Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Cancer Chemother Pharm. 2022;89:431\u201340.","journal-title":"Cancer Chemother Pharm"},{"key":"8330_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3892\/or.2013.2899","volume":"31","author":"T Ui","year":"2014","unstructured":"Ui T, Morishima K, Saito S, Sakuma Y, Fujii H, Hosoya Y, et al. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt\/XIAP pathway. Oncol Rep. 2014;31:619\u201324.","journal-title":"Oncol Rep"},{"key":"8330_CR56","first-page":"6687","volume":"8","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Xie Z, Sun G, Yang P, Li J, Yang H, et al. Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells. Int J Clin Exp Med. 2015;8:6687\u2013701.","journal-title":"Int J Clin Exp Med"},{"key":"8330_CR57","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ijc.26475","volume":"131","author":"M Tatokoro","year":"2012","unstructured":"Tatokoro M, Koga F, Yoshida S, Kawakami S, Fujii Y, Neckers L, et al. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer. 2012;131:987\u201396.","journal-title":"Int J Cancer"},{"key":"8330_CR58","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1074\/jbc.M105568200","volume":"277","author":"C Soti","year":"2002","unstructured":"Soti C, Racz A, Csermely P. A Nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J Biol Chem. 2002;277:7066\u201375.","journal-title":"J Biol Chem"},{"key":"8330_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.5414\/CN108189","volume":"81","author":"KL Ma","year":"2014","unstructured":"Ma KL, Liu J, Gao M, Wang CX, Ni J, Zhang Y, et al. Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal disease. Clin Nephrol. 2014;81:396\u2013404.","journal-title":"Clin Nephrol"},{"key":"8330_CR60","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"8330_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK. mTOR: Role in cancer, metastasis and drug resistance. Semin Cancer Biol. 2019;59:92\u2013111.","journal-title":"Semin Cancer Biol"},{"key":"8330_CR62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.bbrc.2008.05.086","volume":"372","author":"J Martin","year":"2008","unstructured":"Martin J, Masri J, Bernath A, Nishimura RN, Gera J. Hsp70 associates with Rictor and is required for mTORC2 formation and activity. Biochem Biophys Res Commun. 2008;372:578\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"8330_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.07.021","volume":"406","author":"R Calero","year":"2017","unstructured":"Calero R, Morchon E, Martinez-Argudo I, Serrano R. Synergistic anti-tumor effect of 17AAG with the PI3K\/mTOR inhibitor NVP-BEZ235 on human melanoma. Cancer Lett. 2017;406:1\u201311.","journal-title":"Cancer Lett"},{"key":"8330_CR64","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/ijc.28880","volume":"135","author":"SM Chen","year":"2014","unstructured":"Chen SM, Guo CL, Shi JJ, Xu YC, Chen Y, Shen YY, et al. HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer. Int J Cancer. 2014;135:2462\u201374.","journal-title":"Int J Cancer"},{"key":"8330_CR65","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1158\/1078-0432.CCR-06-1331","volume":"12","author":"LK Francis","year":"2006","unstructured":"Francis LK, Alsayed Y, Leleu X, Jia X, Singha UK, Anderson J, et al. Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma. Clin Cancer Res. 2006;12:6826\u201335.","journal-title":"Clin Cancer Res"},{"key":"8330_CR66","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/1535-7163.MCT-16-0848","volume":"16","author":"L Giulino-Roth","year":"2017","unstructured":"Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, et al. Inhibition of Hsp90 suppresses PI3K\/AKT\/mTOR signaling and has antitumor activity in Burkitt lymphoma. Mol Cancer Ther. 2017;16:1779\u201390.","journal-title":"Mol Cancer Ther"},{"key":"8330_CR67","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3349\/ymj.2020.61.7.587","volume":"61","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Gong MK, Yoon CY, Kang J, Yun M, Cho NH, et al. Synergistic antitumor effects of combined treatment with HSP90 inhibitor and PI3K\/mTOR dual inhibitor in cisplatin-resistant human bladder cancer cells. Yonsei Med J. 2020;61:587\u201396.","journal-title":"Yonsei Med J"},{"key":"8330_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0383-6","volume":"9","author":"K Kucharewicz","year":"2018","unstructured":"Kucharewicz K, Dudkowska M, Zawadzka A, Ogrodnik M, Szczepankiewicz AA, Czarnocki Z, et al. Simultaneous induction and blockade of autophagy by a single agent. Cell Death Dis. 2018;9:353.","journal-title":"Cell Death Dis"},{"key":"8330_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122083","volume":"10","author":"M Li","year":"2015","unstructured":"Li M, Yang Z, Vollmer LL, Gao Y, Fu Y, Liu C, et al. AMDE-1 is a dual function chemical for autophagy activation and inhibition. PLoS One. 2015;10:e0122083.","journal-title":"PLoS One"},{"key":"8330_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2014.06.001","volume":"31","author":"A Nagelkerke","year":"2015","unstructured":"Nagelkerke A, Bussink J, Geurts-Moespot A, Sweep FC, Span PN. Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy. Semin Cancer Biol. 2015;31:99\u2013105.","journal-title":"Semin Cancer Biol"},{"key":"8330_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nmeth1010","volume":"4","author":"MZ Li","year":"2007","unstructured":"Li MZ, Elledge SJ. Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods. 2007;4:251\u20136.","journal-title":"Nat Methods"},{"key":"8330_CR72","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1016\/j.molcel.2021.07.023","volume":"81","author":"K Lee","year":"2021","unstructured":"Lee K, Thwin AC, Nadel CM, Tse E, Gates SN, Gestwicki JE, et al. The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state. Mol Cell. 2021;81:3496\u2013508 e5.","journal-title":"Mol Cell"},{"key":"8330_CR73","unstructured":"Schr\u00f6dinger LLC Release 2020-4: Maestro. (New York, NY, 2020)."},{"key":"8330_CR74","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/prot.20660","volume":"61","author":"H Li","year":"2005","unstructured":"Li H, Robertson AD, Jensen JH. Very fast empirical prediction and rationalization of protein pKa values. Proteins. 2005;61:704\u201321.","journal-title":"Proteins"},{"key":"8330_CR75","unstructured":"Case DA et al. Amber22. Amber 2022 edn (University of California, San Francisco., 2022)."},{"key":"8330_CR76","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA, Raguette L, Huang H, Migues AN, et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput. 2020;16:528\u201352.","journal-title":"J Chem Theory Comput"},{"key":"8330_CR77","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1021\/ct500918t","volume":"11","author":"P Li","year":"2015","unstructured":"Li P, Song LF, Merz KM Jr. Systematic parameterization of monovalent ions employing the nonbonded model. J Chem Theory Comput. 2015;11:1645\u201357.","journal-title":"J Chem Theory Comput"},{"key":"8330_CR78","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.1021\/acs.jpcb.8b02250","volume":"122","author":"OHS Ollila","year":"2018","unstructured":"Ollila OHS, Heikkinen HA, Iwai H. Rotational dynamics of proteins from spin relaxation times and molecular dynamics simulations. J Phys Chem B. 2018;122:6559\u201369.","journal-title":"J Phys Chem B"},{"key":"8330_CR79","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/acs.jcim.9b00269","volume":"59","author":"S Schott-Verdugo","year":"2019","unstructured":"Schott-Verdugo S, Gohlke H. PACKMOL-memgen: a simple-to-use, generalized workflow for membrane-protein-lipid-bilayer system building. J Chem Inf Model. 2019;59:2522\u20138.","journal-title":"J Chem Inf Model"},{"key":"8330_CR80","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089\u201392.","journal-title":"J Chem Phys"},{"key":"8330_CR81","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23:327\u201341.","journal-title":"J Comput Phys"},{"key":"8330_CR82","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE 3rd. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9:3084\u201395.","journal-title":"J Chem Theory Comput"},{"key":"8330_CR83","doi-asserted-by":"publisher","first-page":"e19961","DOI":"10.1371\/journal.pone.0019961","volume":"6","author":"CC Lee","year":"2011","unstructured":"Lee CC, Lin TW, Ko TP, Wang AH. The hexameric structures of human heat shock protein 90. PLoS ONE. 2011;6:e19961.","journal-title":"PLoS ONE"},{"key":"8330_CR84","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1021\/acs.jcim.8b00582","volume":"59","author":"J Dittrich","year":"2019","unstructured":"Dittrich J, Schmidt D, Pfleger C, Gohlke H. Converging a knowledge-based scoring function: DrugScore(2018). J Chem Inf Model. 2019;59:509\u201321.","journal-title":"J Chem Inf Model"},{"key":"8330_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","volume":"9","author":"DS Goodsell","year":"1996","unstructured":"Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit. 1996;9:1\u20135.","journal-title":"J Mol Recognit"},{"key":"8330_CR86","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1021\/jm025507u","volume":"45","author":"CA Sotriffer","year":"2002","unstructured":"Sotriffer CA, Gohlke H, Klebe G. Docking into knowledge-based potential fields: a comparative evaluation of DrugScore. J Med Chem. 2002;45:1967\u201370.","journal-title":"J Med Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08330-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:36Z","timestamp":1769536956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08330-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8330"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08330-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods in this study were performed in accordance with the relevant guidelines and regulations. No animals or human subjects were involved in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"130"}}